CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 300784346
- Phone
- (484) 253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,083,076
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,083,076. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −1,650 | $164.14 | $271K | 4,600 |
| 2026-11-11 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −1,467 | $165.78 | $243K | 3,133 |
| 2026-11-11 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −1,133 | $166.76 | $189K | 2,000 |
| 2026-11-11 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −1,200 | $167.75 | $201K | 800 |
| 2026-11-11 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −600 | $168.73 | $101K | 200 |
| 2026-11-11 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −200 | $169.78 | $34K | 0 |
| 2026-11-10 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −100 | $163.34 | $16K | 6,150 |
| 2026-11-10 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −1,449 | $164.85 | $239K | 4,701 |
| 2026-11-10 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −1,651 | $165.85 | $274K | 3,050 |
| 2026-11-10 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −1,500 | $166.91 | $250K | 1,550 |
| 2026-11-10 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −200 | $167.81 | $34K | 1,350 |
| 2026-11-10 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −550 | $169.03 | $93K | 800 |
| 2026-11-10 | Martini Jeffrey S Chief Scientific Officer | Sale 10b5-1 | −800 | $172.12 | $138K | 0 |
Page 1 of 1 · 13 trades